Unequal burdens of COVID-19 infection: a nationwide cohort study of COVID-19-related health inequalities in Korea.

Jeangeun Jeon, Jieun Park, Min-Hyeok Choi, Hongjo Choi, Myoung-Hee Kim
Author Information
  1. Jeangeun Jeon: Department of Sociology, Yonsei University, Seoul, Korea.
  2. Jieun Park: Department of Sociology, Yonsei University, Seoul, Korea.
  3. Min-Hyeok Choi: Department of Preventive and Occupational & Environmental Medicine, Pusan National University Medical College, Yangsan, Korea.
  4. Hongjo Choi: Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, Korea.
  5. Myoung-Hee Kim: Center for Public Health Data Analytics, National Medical Center, Seoul, Korea.

Abstract

OBJECTIVES: While the Korean government's response to the coronavirus disease 2019 (COVID-19) pandemic is considered effective given the relatively low mortality rate, issues of inequality have been insufficiently addressed. This study explored COVID-19-related health inequalities in Korea.
METHODS: Age standardization for various health inequality indices was derived using data from the Korean National Health Insurance Service, the Korea Disease Control and Prevention Agency, and the Microdata Integrated Service of Statistics Korea. The slope index of inequality (SII) and relative index of inequality (RII) were calculated for socioeconomic variables, while absolute difference (AD) and relative difference (RD) were used for gender and disability inequalities.
RESULTS: We observed a number of COVID-19-related health outcome inequalities. Gender inequality was particularly noticeable in infection rates, with the rate of women 1.16 times higher than that of men. In contrast, socioeconomic inequality was evident in vaccination rates, with a 4.5-fold (SII, -4.519; 95% confidence interval, -7.403 to -1.634) difference between the highest and lowest household income groups. Regarding clinical progression post-infection, consistent findings indicated higher risk for men (RD for hospitalization, 0.90; severe cases, 0.54; and fatality, 0.65), individuals with disabilities (RD for hospitalization, 2.27; severe cases, 2.29; and fatality, 2.37), and those from lower socioeconomic groups (SII for hospitalization, 1.778; severe cases, 0.089; and fatality, 0.451).
CONCLUSIONS: While the infection risk was nearly ubiquitous, not everyone faced the same level of risk post-infection. To prevent further health inequalities, it is crucial to develop a thoughtful policy acknowledging individual health conditions and resources.

Keywords

References

  1. Epidemiology. 2015 Jul;26(4):518-27 [PMID: 26000548]
  2. Int J Infect Dis. 2021 Mar;104:742-745 [PMID: 33556610]
  3. Sci Rep. 2021 Dec 28;11(1):24470 [PMID: 34963690]
  4. Front Public Health. 2021 Nov 04;9:769176 [PMID: 34805079]
  5. J Neuroimmune Pharmacol. 2021 Mar;16(1):38-47 [PMID: 33405098]
  6. Lancet Reg Health West Pac. 2021 Feb;7:100088 [PMID: 33521744]
  7. Emerg Infect Dis. 2022 Aug;28(8):1731-1734 [PMID: 35798007]
  8. Lancet Reg Health West Pac. 2023 Jan;30:100581 [PMID: 36093123]
  9. J Epidemiol Community Health. 2020 Nov;74(11):964-968 [PMID: 32535550]
  10. Public Health. 2020 Dec;189:129-134 [PMID: 33227595]
  11. BMC Public Health. 2017 Sep 11;17(1):700 [PMID: 28893212]
  12. J Prev Med Public Health. 2021 Jan;54(1):1-7 [PMID: 33618493]
  13. BMC Public Health. 2021 Jan 15;21(1):144 [PMID: 33451306]
  14. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-8 [PMID: 34614382]
  15. Vaccine. 2018 Jun 14;36(25):3666-3673 [PMID: 29739721]
  16. Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31 [PMID: 24385661]
  17. J Korean Med Sci. 2020 Sep 14;35(36):e328 [PMID: 32924343]
  18. J Korean Med Sci. 2023 Jan 16;38(3):e18 [PMID: 36647218]
  19. BMJ. 2020 Apr 27;369:m1557 [PMID: 32341002]
  20. Int J Equity Health. 2022 Aug 30;21(1):122 [PMID: 36042485]
  21. Epidemiol Health. 2020;42:e2020051 [PMID: 32660216]
  22. Int J Infect Dis. 2020 Jul;96:454-457 [PMID: 32417246]
  23. J Pers Med. 2023 Feb 24;13(3): [PMID: 36983584]
  24. Epidemiol Health. 2021;43:e2021007 [PMID: 33445821]
  25. Int J Environ Res Public Health. 2020 Dec 19;17(24): [PMID: 33352650]
  26. Biol Sex Differ. 2020 May 25;11(1):29 [PMID: 32450906]
  27. PLoS One. 2021 Mar 31;16(3):e0248336 [PMID: 33788848]
  28. Int J Equity Health. 2021 Nov 24;20(1):248 [PMID: 34819081]

MeSH Term

Female
Humans
Male
Cohort Studies
COVID-19
Health Status Disparities
Republic of Korea
Socioeconomic Factors
Pandemics